Bio Matters: Oklahoma bioscience connections figure in California business news
Jim Stafford: The big news involved San Francisco-based Crescendo Bioscience, which was acquired in a $270 million deal by Myriad Genetics of Salt Lake City.
Published: Thursday, May 8, 2014 By: Jim StaffordBreaking business news out of California a few weeks ago turned out to be a big Oklahoma story, although for Oklahomans, the news was sort of like losing your keys only to later discover them in their usual spot.
The big news involved San Francisco-based Crescendo Bioscience, which was acquired in a $270 million deal by Myriad Genetics of Salt Lake City.
Nowhere in the Feb. 4 news release that announced the deal were there mentions of Oklahoma, Riley Genomics or Mike Centola, Ph.D. Yet all three are central to the story.